| Field | Specification |
|---|---|
| Target | |
| Alternative names | Transcription factor A, mitochondrial;mtTFA;Mitochondrial transcription factor 1;MtTF1;Transcription factor 6;TCF-6;Transcription factor 6-like 2;TFAM;TCF6, TCF6L2; |
| UniProt # | |
| Host | |
| Clonality | |
| Isotype | |
| Reactivity | |
| Applications | |
| Immunogen | A synthetic peptide corresponding to a sequence at the N-terminus of human mtTFA, different from the related mouse and rat sequences by five amino acids. |
| Molecular weight | |
| Purification | |
| Reconstitution | |
| Cellular localization | |
| Concentration | |
| Form | Lyophilized |
| Storage | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
This rabbit polyclonal antibody targets transcription factor A, mitochondrial (gene TFAM) in human, mouse and rat samples and is validated for immunoprecipitation, ICC/IF, IHC and Western blot. The predicted molecular weight is 29.1 kDa, and the supplier reports an observed band at about 24 kDa.
Mitochondrial transcription factor A (TFAM) is a DNA-binding protein that packages mitochondrial DNA into nucleoids. It also recruits the mitochondrial RNA polymerase POLRMT to promoters, together with TFB2M, so it controls both mitochondrial transcription and mtDNA copy number and is widely used as a marker of mitochondrial biogenesis.
| Target | Transcription factor A, mitochondrial (gene TFAM; UniProt Q00059, human) |
|---|---|
| Host / Clonality / Isotype | Rabbit / Polyclonal / Rabbit IgG |
| Reactivity | Human, Mouse, Rat |
| Form | Lyophilized |
| Formulation | Per vial: 4 mg trehalose; 0.9 mg NaCl; 0.2 mg Na2HPO4 |
| Calculated MW | 29.1 kDa |
| Observed MW | 24 kDa |
| Storage | As supplied: −20 °C for up to 12 months from receipt. After reconstitution: 4 °C for up to 1 month, or aliquot and keep at −20 °C for up to 6 months. Avoid repeated freeze–thaw cycles. |
Validated Applications
| Western blot | 0.1–0.5 µg/mL (Human, Mouse, Rat) |
|---|---|
| IHC (paraffin sections) | 2–5 µg/mL (Human) |
| Immunocytochemistry / Immunofluorescence | 5 µg/mL (Human) |
| Immunoprecipitation | 0.5–2 µg/mL (Human) |
Samples with a confirmed band (WB): human 293T cells, human K562 cells, human Caco-2 cells, human Raji cells, rat brain tissue, rat PC-12 cells, mouse brian tissue, mouse NIH/3T3 cells.
Recommended loading (WB): 20–40 µg of total protein per lane.
Conditions in the example images (WB): 12% SDS-PAGE under reducing conditions, 30 µg lysate per lane, transfer to nitrocellulose membrane, blocking in 5% non-fat milk, primary antibody at 0.5 µg/mL overnight at 4 °C, HRP-conjugated secondary antibody at 1:5000, ECL detection.
Samples with confirmed staining (IHC): human liver cancer tissue, human pancrease cancer tissue.
Recommended antigen retrieval: heat-mediated, in TE buffer (pH 9.0); citrate buffer (pH 6.0) can be used instead.
Conditions in the example images (IHC): heat-mediated antigen retrieval in EDTA buffer (pH 8.0).
Samples with confirmed staining (ICC/IF): U2OS cells.
Samples with a confirmed result (IP): K562 cells.
Immunogen
Synthetic peptide from the N-terminal region of human mtTFA. It differs from the mouse and rat sequences at five residues.
Reactivity Notes
The supplier lists reactivity with human, mouse and rat. UniProt places transcription factor A, mitochondrial in the mitochondrion. The samples tested by the supplier (listed above) are a practical starting point for positive controls.
Safety
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
Yena Cho et al. (2024) CARM1 phosphorylation at S595 by p38γ MAPK drives ROS-mediated cellular senescence. Redox Biology. 10.1016/j.redox.2024.103344
Camille H. Bourcier et al. (2023) ß1-adrenergic blockers preserve neuromuscular function by inhibiting the production of extracellular traps during systemic inflammation in mice. Frontiers in Immunology. 10.3389/fimmu.2023.1228374
Hai-Yan Ni et al. (2022) Seed oil of Rosa roxburghii Tratt against non-alcoholic fatty liver disease in vivo and in vitro through PPARα/PGC-1α-mediated mitochondrial oxidative metabolism. Phytomedicine. 10.1016/j.phymed.2021.153919
Ping Meng et al. (2022) CXC Chemokine Receptor 2 Accelerates Tubular Cell Senescence and Renal Fibrosis via β-Catenin-Induced Mitochondrial Dysfunction. Frontiers in Cell and Developmental Biology. 10.3389/fcell.2022.862675
Mingsheng Zhu et al. (2022) AMPK Activator O304 Protects Against Kidney Aging Through Promoting Energy Metabolism and Autophagy. Frontiers in Pharmacology. 10.3389/fphar.2022.836496
Bingna Cai et al. (2023) Anti-fatigue effects and mechanism of Syngnathus schlegeli peptides supplementation on exercise-fatigued mice. Journal of Functional Foods. 10.1016/j.jff.2023.105846
Shan Zhou et al. (2021) Cannabinoid receptor 2 plays a central role in renal tubular mitochondrial dysfunction and kidney ageing. Journal of Cellular and Molecular Medicine. 10.1111/jcmm.16857
Jin Zhaoya et al. (2026) FTO-mediated m6A demethylation regulates PGC-1α-dependent mitochondrial biogenesis to attenuate aluminum-induced neuronal senescence. Scientific Reports. 10.1038/s41598-026-51674-w
Xueping Liu et al. (2024) Toxicity mechanism of acrolein on energy metabolism disorder and apoptosis in human ovarian granulosa cells. Toxicology. 10.1016/j.tox.2024.153861
Ru-Ting Li et al. (2025) Sini-Suanzaoren decoction regulates mitochondrial biogenesis mediated by MT-SIRT1 in the treatment of insomnia rats. World Journal of Psychiatry. 10.5498/wjp.v15.i12.108867
